BPG is committed to discovery and dissemination of knowledge
Case Report
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Nov 6, 2025; 13(31): 110620
Published online Nov 6, 2025. doi: 10.12998/wjcc.v13.i31.110620
Preventing transmission of dyschromatosis universalis hereditaria through preimplantation genetic testing: A case report
Xue-Lian Wang, Tong Zou, Yi-Cheng Wu, You-Yi Weng, Qiang Yao, Wei-Wei Sun
Xue-Lian Wang, Tong Zou, Yi-Cheng Wu, Qiang Yao, Wei-Wei Sun, Department of Obstetrics and Gynecology, West China Second University Hospital, Chengdu 610041, Sichuan Province, China
Xue-Lian Wang, Tong Zou, Yi-Cheng Wu, Qiang Yao, Wei-Wei Sun, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu 610041, Sichuan Province, China
You-Yi Weng, Department of Obstetrics and Gynecology, Sichuan Tianfu New Area People's Hospital, Chengdu 610041, Sichuan Province, China
Author contributions: Sun WW, Yao Q, and Zou T contributed ideas about this case; Wang XL, Zou T, and Wu YC wrote the manuscript; Wang XL, Weng YY, and Yao Q revised the manuscript; Wang XL and Sun WW provide the follow-up care of the patient and the baby. All authors have read and approved the final manuscript.
Informed consent statement: Written informed consent was obtained from the patient for publication of this report and any accompanying images.
Conflict-of-interest statement: All authors declare no conflict of interest for this case report.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Wei-Wei Sun, MD, Chief Physician, Department of Obstetrics and Gynecology, West China Second University Hospital, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, No. 20 Section 3, South Renmin Road, Chengdu 610041, Sichuan Province, China. weiweisun@scu.edu.cn
Received: June 11, 2025
Revised: July 10, 2025
Accepted: September 9, 2025
Published online: November 6, 2025
Processing time: 141 Days and 20.6 Hours
Abstract
BACKGROUND

Dyschromatosis universalis hereditaria (DUH) is a rare type of autosomal dominant inheritance disease. It has varying gene mutation sites among different ethnicities. SASH1 and ABCB6 have been identified as the causative genes of this disorder.

CASE SUMMARY

A 30-year-old woman presented with irregular black pigmentation spots to our department. Upon examination, the pigmentations were found to be especially dense on the extremities and the face. She had no family history of inbreeding, nor any previous chemical exposure. Genetic testing confirmed that the disease occurred because the patient has a SASH1 gene mutation. Following the use of assisted reproductive technology and preimplantation genetic testing for monogenic disorders, the patient give birth to a health baby.

CONCLUSION

Using assisted reproductive technology/preimplantation genetic testing for monogenic disorders is an option for DUH patients to reduce the risk of transmitting the pathogenic variant to their offspring.

Keywords: Dyschromatosis universalis hereditaria; SASH1; Pigmentation; Assisted reproductive technology; Preimplantation genetic testing; Monogenic gene diseases; Case report

Core Tip: This case report presents a woman with dyschromatosis universalis hereditaria (DUH) carrying a novel SASH1 variant. By applying preimplantation genetic testing for monogenic disorders (PGT-M) with assisted reproductive technology, an unaffected embryo was selected, leading to the birth of a healthy child. The report highlights PGT-M as a promising approach to reduce DUH transmission, emphasizing the role of genetic counseling and long-term follow-up.